Scientists develop new protocol to ready induced pluripotent stem cell clinical application

Scientists have developed a new way to generate induced pluripotent stem cell lines from human fibroblasts, acquired from both healthy and diseased donors. This cell-sorting method consistently selects the highest quality, standardized iPS cells, representing a major step forward for drug discovery and the development of cell therapies.

Read the whole article on Science Daily

More from Science Daily